Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for diabetic maculopathy].

B Kalvodová1, P Oudová

  • 1Ocní klinika VFN a 1. LF UK, Praha.

Ceska a Slovenska Oftalmologie : Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti
|February 21, 2002
PubMed
Summary

Diabetic maculopathy (DMP) causes vision loss in diabetes patients. This study details its pathogenesis, classification, diagnosis, and treatment, including concurrent conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TREATMENT OPTIONS FOR PREMACULAR AND SUB-INTERNAL LIMITING MEMBRANE HEMORRHAGE.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2022
Same author

OCT Findings and Long-term Follow-up Results of Vitrectomy in Patients with Optic Disc Pit and Associated Maculopathy.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2018
Same author

[Two-Year Follow-up Results of Patients with Macular Oedema Due to Retinal Vein Occlusion Treated with Ranibizumab].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2017
Same author

[Recommendations for diagnosis and therapy of diabetic retinopathy].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2013
Same author

[Present state of diagnostic and screening of the diabetic retinopathy and diabetic macular oedema].

Vnitrni lekarstvi·2013
Same author

[Problematic issues related to screening for diabetic retinopathy].

Vnitrni lekarstvi·2013

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Diabetology

Context:

  • Diabetic maculopathy (DMP) is a leading cause of vision impairment in individuals with type 1 and type 2 diabetes mellitus (DM).
  • Understanding the pathogenesis of diabetic macular edema (DME) is crucial for effective management.
  • Current treatment standards for DMP require comprehensive evaluation.

Purpose:

  • To investigate the pathogenesis of diabetic macular edema (DME).
  • To outline the classification, diagnosis, and standard treatment protocols for DMP.
  • To review therapeutic procedures for DMP, particularly when co-occurring with proliferative diabetic retinopathy in DM types 1 and 2.

Summary:

  • This work explores the mechanisms underlying diabetic macular edema (DME).
  • It provides a classification and diagnostic framework for diabetic maculopathy (DMP).
  • The study details current treatment standards and therapeutic options for DMP, including complex cases with proliferative diabetic retinopathy.

Impact:

  • Improved understanding of DMP pathogenesis can lead to targeted therapies.
  • Standardized classification and diagnosis enhance patient care and research consistency.
  • Comprehensive treatment guidelines aid clinicians in managing diabetic vision loss effectively.

Related Experiment Videos